The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty big deal,” Gupta said. “As you just mentioned, it’s been since 1998 that ...

Trump, Hosting Israel’s Leader, Says Palestinians Should Leave Gaza “They have no alternative right now” but to leave, President Trump said shortly before he welcomed Prime Minister Benjamin ...

Search engines, GPS maps and other tech can alter our ability to learn and remember. Now scientists are working out what AI ...